Dr. Ho-Yi DAO
Speaker
Appointment(s)
Associate Consultant,
Department of Medicine and Geriatrics,
Tuen Mun Hospital,
Hong Kong SAR
Speaker Biography
Dr. Ho Yi DAO is currently the Associate Consultant in the Department of Medicine and Geriatrics at Tuen Mun Hospital. She obtained her medical degree from The Chinese University of Hong Kong in 2012. Dr. DAO joined Tuen Mun Hospital since 2012 and completed her specialist training in Endocrinology, Diabetes and Metabolism at Tuen Mun Hospital in 2019.
She has extensive experience in managing diabetes in patients with heterogeneous medical backgrounds and various end organ or functional impairments.
Furthermore, she has been contributing to establishment of various clinical protocols regarding Endocrine disease and diabetes management in New Territories West Cluster. Her latest work involves joint establishment of pre-colonoscopy diabetes management protocol from 2024 to 2025.
She has extensive experience in managing diabetes in patients with heterogeneous medical backgrounds and various end organ or functional impairments.
Furthermore, she has been contributing to establishment of various clinical protocols regarding Endocrine disease and diabetes management in New Territories West Cluster. Her latest work involves joint establishment of pre-colonoscopy diabetes management protocol from 2024 to 2025.
Modifying and Adjusting T2D Treatment for Older Patients with Sarcopenia
Abstract:
Sarcopenia, the age-related progressive loss of muscle mass and strength is intertwined with diabetes. Not only do these two conditions share similar risk factors, they also impact each other. In view of highly heterogeneous medical backgrounds in the elderly and the more frail populations, the latest guidelines from the American Diabetes Association (ADA) recommended the 4Ms framework (mentation, medications, mobility and what matters most) to tailor individual diabetes treatment goals and therapeutic approaches.In this lecture, Dr. DAO will discuss the relationships between sarcopenia and diabetes. Updates from latest guidelines on clinical assessments and management in elderly diabetic patients will be reviewed. She will also share her insights on selection of diabetic medications in elderly patients with sarcopenia. Last but not least, illustrations by case sharing will also address practical strategies in optimizing diabetes control while minimizing hypoglycaemia or complications in this group of patients.
Sarcopenia, the age-related progressive loss of muscle mass and strength is intertwined with diabetes. Not only do these two conditions share similar risk factors, they also impact each other. In view of highly heterogeneous medical backgrounds in the elderly and the more frail populations, the latest guidelines from the American Diabetes Association (ADA) recommended the 4Ms framework (mentation, medications, mobility and what matters most) to tailor individual diabetes treatment goals and therapeutic approaches.In this lecture, Dr. DAO will discuss the relationships between sarcopenia and diabetes. Updates from latest guidelines on clinical assessments and management in elderly diabetic patients will be reviewed. She will also share her insights on selection of diabetic medications in elderly patients with sarcopenia. Last but not least, illustrations by case sharing will also address practical strategies in optimizing diabetes control while minimizing hypoglycaemia or complications in this group of patients.